Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
The International Journal of Biochemistry & Cell Biology|February 6, 2014
Coenzyme Q10 as a therapy for mitochondrial diseaseI P HargreavesBritish Journal of Hospital Medicine (London, England : 2005)|October 8, 2019
Supplementation with selenium and coenzyme Q10 in critically ill patientsI P Hargreaves, D MantleAmino Acids|October 24, 2002
Homocysteine and cysteine - albumin binding in homocystinuria: assessment of cysteine status and implications for glutathione synthesis?I P Hargreaves, P J Lee, A BriddonJournal of Inherited Metabolic Disease|December 22, 1999
Mitochondrial respiratory chain defects are not accompanied by an increase in the activities of lactate dehydrogenase or manganese superoxide dismutase in paediatric skeletal muscle biopsiesI P Hargreaves, S J Heales, J M LandDevelopmental Neuroscience|December 9, 2000
Nitric-oxide-induced inhibition of mitochondrial complexes following aglycaemic hypoxia in neonatal cortical rat brain slicesK J Brooks, I P Hargreaves, T E BatesJournal of Inherited Metabolic Disease|February 11, 2005
Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatmentI P Hargreaves, Y Sheena, J M Land, et al.Journal of Inherited Metabolic Disease|April 23, 2003
Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patientsI P Hargreaves, S J R Heales, A Briddon, et al.Journal of Inherited Metabolic Disease|January 27, 2009
Mitochondrial cytochrome c release: a factor to consider in mitochondrial disease?M L S Oppenheim, I P Hargreaves, S Pope, et al.Mitochondrion|March 31, 2007
Inhibition of mitochondrial complex IV leads to secondary loss complex II-III activity: implications for the pathogenesis and treatment of mitochondrial encephalomyopathiesI P Hargreaves, A J Duncan, L Wu, et al.Biochemical and Biophysical Research Communications|February 8, 2005
Chlorimipramine: a novel anticancer agent with a mitochondrial targetE Daley, D Wilkie, A Loesch, et al.Pageof 2